Area of research
Rheumatology · Nephrology
Research interest
Research interests include Systemic Lupus Erythematosus Research, Renal Diseases and Glomerulopathies, Pregnancy and Medication Impact, and COVID-19 Clinical Research Studies.
The unique challenges of childhood-onset systemic lupus erythematosus and lupus nephritis patients: a proposed framework for an individualized transitional care plan.
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial
Capacity for the management of kidney failure in the International Society of Nephrology Western Europe region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)
Pregnancy in women with nephrotic-range proteinuria: A retrospective cohort study.
Gender Equity in Academic Nephrology: Enough Talk, Now Is the Time to Act.
Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY
Effect of belimumab on kidney-related outcomes in patients with lupus nephritis: post hoc subgroup analyses of the phase 3 BLISS-LN trial
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan
COVID-19 in Patients with Glomerular Disease: Follow-Up Results from the IRoc-GN International Registry.
Immune gene expression and functional networks in distinct lupus nephritis classes.
Comparison of catheters or new arteriovenous fistulas for commencement of haemodialysis in pregnant women with chronic kidney disease: an international observational study.
A Focus Group Study of Self-Management in Patients With Glomerular Disease.
BLISS-LN trial revisited: function matters.
COVID-19 in patients with glomerular disease.
Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine.
Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression.
Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus : A Randomized Controlled Trial.
Type I interferons affect the metabolic fitness of CD8<sup>+</sup> T cells from patients with systemic lupus erythematosus.
The impact of chronic kidney disease Stages 3-5 on pregnancy outcomes.
Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients.
Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection.
Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring.
Placental and endothelial biomarkers for the prediction of superimposed pre-eclampsia in chronic kidney disease
Informing the Risk of Kidney Transplantation Versus Remaining on the Waitlist in the Coronavirus Disease 2019 Era.
Identification of Patient Characteristics Associated With SARS-CoV-2 Infection and Outcome in Kidney Transplant Patients Using Serological Screening.
Placental and endothelial biomarkers for the prediction of superimposed pre-eclampsia in chronic kidney disease.
Anti-Müllerian hormone concentrations in women with chronic kidney disease.
Comparison of humoral and cellular responses in kidney transplant recipients receiving BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines
Comparison of immunogenicity between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in a large haemodialysis population